<DOC>
	<DOC>NCT02177565</DOC>
	<brief_summary>Do mesenchymal stem cells accelerate new bone formation in persistent non-unions.</brief_summary>
	<brief_title>Autologous Stem Cell Therapy for Fracture Non-union Healing</brief_title>
	<detailed_description>Do mesenchymal stem cells accelerate new bone formation in persistent non-unions treated with carrier plus in vitro expanded autologous BMSCs or carrier alone (control). Secondary aims were to analyze predictors of union in these patients and describe adverse events at final follow-up.</detailed_description>
	<mesh_term>Fractures, Bone</mesh_term>
	<mesh_term>Fractures, Ununited</mesh_term>
	<criteria>An established nonunion according to the US Food &amp; Drug Administration criteria14. Nonunion following fracture of tibia or femur suitable for synthetic bone grafting. 1. Skeletal immaturity. 2. Pregnant or breastfeeding. 3. Nonunion following pathological fractures. 4. Positive to Hepatitis B, HepatitisC or HIV. 5. Infection during BMSC culture.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Non-union</keyword>
	<keyword>fracture</keyword>
	<keyword>bone marrow stem cells</keyword>
</DOC>